These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17214576)

  • 1. Signaling abnormalities in systemic lupus erythematosus as potential drug targets.
    Fernandez D; Bonilla E; Phillips P; Perl A
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):305-11. PubMed ID: 17214576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.
    Fernandez D; Bonilla E; Mirza N; Niland B; Perl A
    Arthritis Rheum; 2006 Sep; 54(9):2983-8. PubMed ID: 16947529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Signal transduction abnormalities in systemic lupus erythematosus].
    Nagy G; Géher P; Koncz A; Perl A
    Orv Hetil; 2005 Jul; 146(31):1625-30. PubMed ID: 16158611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus.
    Nagy G; Perl A
    Clin Immunol; 2006; 118(2-3):145-51. PubMed ID: 16406340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell and B-cell signaling biomarkers and treatment targets in lupus.
    Perl A; Fernandez DR; Telarico T; Doherty E; Francis L; Phillips PE
    Curr Opin Rheumatol; 2009 Sep; 21(5):454-64. PubMed ID: 19550330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic control of T cell activation and death in SLE.
    Fernandez D; Perl A
    Autoimmun Rev; 2009 Jan; 8(3):184-9. PubMed ID: 18722557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells.
    Nagy G; Barcza M; Gonchoroff N; Phillips PE; Perl A
    J Immunol; 2004 Sep; 173(6):3676-83. PubMed ID: 15356113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus.
    Perl A; Hanczko R; Doherty E
    Methods Mol Biol; 2012; 900():61-89. PubMed ID: 22933065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
    Guo Q; Chen XY; Su Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus.
    Perl A; Gergely P; Banki K
    Int Rev Immunol; 2004; 23(3-4):293-313. PubMed ID: 15204090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus.
    Gergely P; Niland B; Gonchoroff N; Pullmann R; Phillips PE; Perl A
    J Immunol; 2002 Jul; 169(2):1092-101. PubMed ID: 12097418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus.
    Cao S; Jiang J; Yin H; Wang L; Lu Q
    Int Immunopharmacol; 2024 Jun; 134():112149. PubMed ID: 38692019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Tsokos GC
    Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.
    Gergely P; Grossman C; Niland B; Puskas F; Neupane H; Allam F; Banki K; Phillips PE; Perl A
    Arthritis Rheum; 2002 Jan; 46(1):175-90. PubMed ID: 11817589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of systemic lupus erythematosus - From the viewpoint of oxidative stress and mitochondrial dysfunction.
    Lee HT; Wu TH; Lin CS; Lee CS; Wei YH; Tsai CY; Chang DM
    Mitochondrion; 2016 Sep; 30():1-7. PubMed ID: 27235747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased SAP Expression in T Cells from Patients with Systemic Lupus Erythematosus Contributes to Early Signaling Abnormalities and Reduced IL-2 Production.
    Karampetsou MP; Comte D; Kis-Toth K; Terhorst C; Kyttaris VC; Tsokos GC
    J Immunol; 2016 Jun; 196(12):4915-24. PubMed ID: 27183584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging views of mitophagy in immunity and autoimmune diseases.
    Xu Y; Shen J; Ran Z
    Autophagy; 2020 Jan; 16(1):3-17. PubMed ID: 30951392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?
    Fernandez D; Perl A
    Discov Med; 2010 Mar; 9(46):173-8. PubMed ID: 20350481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.
    Nagy G; Koncz A; Telarico T; Fernandez D; Ersek B; Buzás E; Perl A
    Arthritis Res Ther; 2010; 12(3):210. PubMed ID: 20609263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.